Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Seattle, Washington 25 trials found
New Search
Filter
Trial Phase
Study Type
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Clinical Pre-screening Protocol for Ovarian Cancer
N/AOBSERVATIONAL Tampa, Florida +4 more
RECRUITING
Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer
PHASE2INTERVENTIONAL Oklahoma City, Oklahoma +1 more
RECRUITING
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
PHASE2INTERVENTIONAL West Los Angeles, California +4 more
RECRUITING
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
PHASE2INTERVENTIONAL Boston, Massachusetts +1 more
RECRUITING
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
PHASE1, PHASE2INTERVENTIONAL Tampa, Florida +4 more
RECRUITING
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
N/AOBSERVATIONAL Mesa, Arizona +4 more
RECRUITING
PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer
NAINTERVENTIONAL Seattle, Washington
RECRUITING
Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study
PHASE2INTERVENTIONAL Pittsburgh, Pennsylvania +1 more
RECRUITING
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
PHASE1INTERVENTIONAL Duarte, California +4 more
RECRUITING
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
NAINTERVENTIONAL Chicago, Illinois +4 more
RECRUITING
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer
PHASE2INTERVENTIONAL Seattle, Washington
RECRUITING
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
PHASE2INTERVENTIONAL San Diego, California +4 more
RECRUITING
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
PHASE1INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
PHASE2INTERVENTIONAL Sacramento, California +4 more
RECRUITING
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
N/AOBSERVATIONAL Duarte, California +4 more
RECRUITING
AIMS Cancer Outcomes Study
N/AOBSERVATIONAL Seattle, Washington
RECRUITING
Filter Trials
Trial Phase
Study Type